Related Articles
Association of histone deacetylase expression with histology and prognosis of ovarian cancer
Nedaplatin and irinotecan combination therapy is equally effective and less toxic than cisplatin and irinotecan for patients with primary clear cell adenocarcinoma of the ovary and recurrent ovarian carcinoma
Prognosis of ovarian clear cell cancer compared with other epithelial cancer types: A population‑based analysis
Survival analysis of ovarian clear cell carcinoma confined to the ovary with or without comprehensive surgical staging
Modulation of estrogenic action in clear cell carcinoma of the ovary (Review)